Roxane Owes $2M In Attys' Fees In 'Exceptional' Patent Row
A New Jersey federal judge has ordered Roxane Laboratories Inc. to pay $2 million in legal fees in a patent infringement claim against two generic-drug makers over a kidney medication, a...To view the full article, register now.
Already a subscriber? Click here to view full article